BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5323247)

  • 1. [Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
    Wagner K; Haas H; Meyerhold A
    Wien Klin Wochenschr; 1965 Sep; 77(36):589-602. PubMed ID: 5323247
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Hodgkin's disease with Natulan].
    Anglesio E
    Minerva Med; 1965 Dec; 56(100):4402-6. PubMed ID: 5324896
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
    Nissen I; Poulsen EH
    Ugeskr Laeger; 1967 Nov; 129(44):1472-6. PubMed ID: 4875225
    [No Abstract]   [Full Text] [Related]  

  • 4. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
    Spies SK; Snyman HW
    S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
    Danieli G
    G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
    Zarrilli D; Perrone V; Pergola M
    Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
    Hansen MM; Hertz H; Videaek A
    Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
    [No Abstract]   [Full Text] [Related]  

  • 9. [Report of a case of Lyell's syndrome during a course of treatment with Natulan].
    Garbarini U; Valassina GP
    Minerva Med; 1973; 64(53):2775-8. PubMed ID: 4580162
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methylhydrazine in the therapy of malignant lymphopathies].
    Beltrametti L; Almici C
    Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

  • 12. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
    Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatment of malignant granuloma with Natulan Roche].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kolakowska-Polubiec K; Polubiec A
    Wiad Lek; 1968 Aug; 21(16):1417-9. PubMed ID: 5699696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of procarbazine in malignant lymphomas].
    Fiorentino M; Finotto E
    Presse Med (1893); 1968 Apr; 76(21):992. PubMed ID: 4872010
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
    Holsti LR; Hjelt AL
    Ann Med Intern Fenn; 1967; 56(3):119-24. PubMed ID: 5630600
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of lymphomas with antineoplastic agents.
    Brunk SF
    J Iowa Med Soc; 1968 Oct; 58(10):1038-41. PubMed ID: 4884154
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy of malignant hemoreticulopathy].
    Israël L
    Rev Tuberc Pneumol (Paris); 1968; 32(5):666-7. PubMed ID: 4885657
    [No Abstract]   [Full Text] [Related]  

  • 18. [Natulan (experimental and clinical data on its antitumor effect)].
    Brodskaia NA
    Vopr Onkol; 1972; 18(11):101-9. PubMed ID: 4566561
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of combined chemotherapy of malignant lymphoma at the hematological department of the clinical hospital in Belgrade].
    Plécas V; Dragović M; Vidaković B; Jelić S; Obradović M
    Srp Arh Celok Lek; 1976 Sep; 104(9):645-52. PubMed ID: 800287
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with the cytostatic drug natulan].
    Kohout J
    Med Klin; 1969 May; 64(19):898-901. PubMed ID: 5819002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.